178 related articles for article (PubMed ID: 11745444)
1. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.
Saedi MS; Zhu Z; Marker K; Liu RS; Carpenter PM; Rittenhouse H; Mikolajczyk SD
Int J Cancer; 2001 Nov; 94(4):558-63. PubMed ID: 11745444
[TBL] [Abstract][Full Text] [Related]
2. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells.
Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS
Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.
Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ
Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585
[TBL] [Abstract][Full Text] [Related]
4. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
[TBL] [Abstract][Full Text] [Related]
5. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.
Magklara A; Scorilas A; Stephan C; Kristiansen GO; Hauptmann S; Jung K; Diamandis EP
Urology; 2000 Sep; 56(3):527-32. PubMed ID: 10962338
[TBL] [Abstract][Full Text] [Related]
6. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.
Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW
Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557
[TBL] [Abstract][Full Text] [Related]
7. Expression of human glandular kallikrein, hK2, in mammalian cells.
Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
[TBL] [Abstract][Full Text] [Related]
8. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
[TBL] [Abstract][Full Text] [Related]
10. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.
Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O
Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755
[TBL] [Abstract][Full Text] [Related]
11. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.
Thorek DL; Evans MJ; Carlsson SV; Ulmert D; Lilja H
Thromb Haemost; 2013 Sep; 110(3):484-92. PubMed ID: 23903407
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.
Ylikoski A; Karp M; Pettersson K; Lilja H; Lövgren T
J Mol Diagn; 2001 Aug; 3(3):111-22. PubMed ID: 11486050
[TBL] [Abstract][Full Text] [Related]
14. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.
Réhault S; Monget P; Mazerbourg S; Tremblay R; Gutman N; Gauthier F; Moreau T
Eur J Biochem; 2001 May; 268(10):2960-8. PubMed ID: 11358513
[TBL] [Abstract][Full Text] [Related]
16. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
[TBL] [Abstract][Full Text] [Related]
17. Identification of human glandular kallikrein hK2 from LNCaP cells.
Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ
J Androl; 1996; 17(4):353-9. PubMed ID: 8889697
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2.
Klee GG; Goodmanson MK; Jacobsen SJ; Young CY; Finlay JA; Rittenhouse HG; Wolfert RL; Tindall DJ
Clin Chem; 1999 Jun; 45(6 Pt 1):800-6. PubMed ID: 10351988
[TBL] [Abstract][Full Text] [Related]
19. Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.
Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
Int J Cancer; 1999 May; 81(3):438-42. PubMed ID: 10209959
[TBL] [Abstract][Full Text] [Related]
20. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]